2Adair J R,Athwal D S,BodmerM W,et al.Humanization of the murineanti-human CD3 monoclonal antibody OKT3[J].Human antibodies Hybridomas,1994,5(1～2):41.
3Asvadi P,Fletcher A,Raison R L.Expression and functional analysis of re combinant scFv and diabody fragments with specificity for humanRhD[J].Jmol Recognit,2002,1s(5):321～330.
4Azemar M.Schmidt M,Arlt F,et al.Recombinant antibody toxins specific for ErbB2 and EGF receptor inhibit the mvitro growth of human head and neck cancer cells and cause rapid tumor regression in vivo[J].Int J Cancer.2000,86(2):269-275.
5Cornelia M,ZuzanaL M,Sandra S,et al.Isohfionand character-ization of a scFv antibody specific for tumor endothe-lialmarkerl(TEM1),anewreagent for targeted turnor therapy[J].Cancer Lett,2006,235(2):298～308.
6DeNardo S J.Radioimmunodetection and therapy of breas cancer[J].Semin Nud Med,2005,35(2):143～151.
7Duan L,Bagasra O.Laughlin M A,et al.Potent inhibition of human im munodetlciency virus type I replication by and intracellulac anti-Key single chain antibody[J].Proc Natl Acad sci UAS,1994,91:5075.
8Goncalves J,Silva F,Freitas-Vieira A,et al.Functioml neutralization of HIV-1 Vif protein bv intracellular immunization inhibit reverse transcription and viral replication[J].J Boil Chem,2002,277(35):32036～32045.
9Hao H J,Jing Y Q,Zheng Y L.et al.Improved stability an yield of Fvtargeted super antigen by introducing both linker and disulfide bond into the targeting moiety[J].Biochimie,2005,87(8):661～667.
10Myers K A.Kyan M G,Stem P L,et al.Targeting immune effector molecules to human tumor cells through genetic delivery of 5T42 specific scFv fusion proteins[J].Cancer Gene Ther,2002,9(11):884～896.
